Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders

The present invention provides peptides and peptide analogues that mimic the structural and pharmacological properties of human ApoA-I. The peptides and peptide analogues are useful to treat a variety of disorders associated with dyslipidemia.

Saved in:
Bibliographic Details
Main Authors Dasseux, Jean-Louis, Sekul, Renate, Buttner, Klaus, Cornut, Isabelle, Metz, Gunther
Format Patent
LanguageEnglish
Published 09.01.2003
Online AccessGet full text

Cover

More Information
Summary:The present invention provides peptides and peptide analogues that mimic the structural and pharmacological properties of human ApoA-I. The peptides and peptide analogues are useful to treat a variety of disorders associated with dyslipidemia.